Onyx Biotec Limited (NSE:ONYX)
33.00
0.00 (0.00%)
At close: Mar 6, 2026
Onyx Biotec Market Cap
Onyx Biotec has a market cap or net worth of 598.36 million as of March 10, 2026. Its market cap has decreased by -51.79% in one year.
Market Cap
598.36M
Enterprise Value
683.76M
Revenue
663.87M
Ranking
n/a
PE Ratio
50.93
Stock Price
33.00
Market Cap Chart
Since November 22, 2024, Onyx Biotec's market cap has decreased from 1.03B to 598.36M, a decrease of -41.85%. That is a compound annual growth rate of -34.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 598.36M | -19.12% |
| Dec 31, 2025 | 739.79M | -54.46% |
| Dec 31, 2024 | 1.62B | 57.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Godavari Drugs | 604.62M |
| Phaarmasia | 583.71M |
| Shelter Pharma | 561.31M |
| Asston Pharmaceuticals | 664.01M |
| Mangalam Drugs & Organics | 525.02M |
| Amwill Health Care | 700.13M |
| Biofil Chemicals and Pharmaceuticals | 493.26M |
| Accretion Pharmaceuticals | 763.11M |